A novel form of prostate-specific antigen transcript produced by alternative splicing

Cancer Research

Volumn 60, Issue 1, 2000, Pages 56-59

  Tanaka, Tsutomu ^a   Isono, Takahiro ^a   Yoshiki, Tatsuhiro ^a   Yuasa, Takeshi ^a   Okada, Yusaku ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; GENE DELETION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALTERNATIVE SPLICING; BASE SEQUENCE; BLOTTING, WESTERN; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033966958     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Silverberg, E., Boring, C. C., and Squires, T. S. Cancer statistics, 1990. CA Cancer J. Clin., 40: 9-26, 1990.
2. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., and Redwine, E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med., 317: 909-916, 1987.
3. Arai, Y., Yoshiki, T., and Yoshida, O. Prognostic significance of prostate specific antigen in endocrine treatment for prostatic cancer. J. Urol., 144: 1415-1419, 1990.
4. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J., Petros, J. A., Andriole, G. L., Stenman, U. H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K., and Alfthan, O. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med., 324: 1156-1161, 1991.
5. 1-antichymotrypsin as an indicator of prostate cancer. J. Urol., 150: 100-105, 1993.
6. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222-226, 1991.
7. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff, T. L., and Nadler, R. B. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J. Am. Med. Assoc., 274: 1214-1220, 1995.
8. Yuasa, T., Yoshiki, T., Tanaka, T., Kim, C. J., Isono, T., and Okada, Y. Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma. Jpn. J. Cancer Res., 89: 879-882, 1998.
9. McCormack, R. T., Rittenhouse, H. G., Finlay, J. A., Sokoloff, R. L., Wang, T. J., Wolfert, R. L., Lilja, H., and Oesterling, J. E. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology, 45: 729-744, 1995.
10. Baffa, R., Moreno, J. G., Monne, M., Veronese, M. L., and Gomella, L. G. A comparative analysis of prostate-specific antigen gene sequence in benign and malignant prostate tissue. Urology, 47: 795-800, 1996.
11. Sanger, F., Nicklens, S., and Coulson, A. R. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
12. Yoshiki, T., Herr, J. C., and Lee, C. Y. G. Purification and characterization of a sperm antigen recognized by HSA-5 monoclonal antibody. J. Reprod. Immunol., 29: 209-222, 1995.
13. Belanger, A., van Halbeek, H., Graves, H. C., Grandbois, K., Stamey, T. A., Huang, L., Poppe, I., and Labrie, F., Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate, 27: 187-197, 1995.
14. Benson, M. C., Whang, I. S., Pantuck, A., Ring, K., Kaplan, S. A., Olsson, C. A., and Cooner, W. H. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J. Urol., 147: 815-816, 1992.
15. Carter, H. B., Morrell, C. H., Pearson, J. D., Brant, L. J., Plato, C. C, Metter, E. J., Chan, D. W., Fozard, J. L., and Walsh, P. C. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. Cancer Res., 52: 3323-3328, 1992.
16. Mount, S. M. A catalogue of splice junction sequences. Nucleic Acids Res., 10: 459-472, 1982.
17. Riegman, P. H., Klaassen, P., van der Korput, J. A., Romijn, J. C., and Trapman, J. Molecular cloning and characterization of novel prostate antigen cDNAs. Biochem. Biophys. Res. Commun., 155: 181-188, 1988.
18. Henttu, P., Lukkarinen, O., and Vihko, P. Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate. Int. J. Cancer, 45: 654-660, 1990.
19. Heuze, N., Olayat, S., Gutman, N., Zani, M. L., and Courty, Y. Molecular cloning and expression of an alternative hKLK3 transcript coding for a variant protein of prostate-specific antigen. Cancer Res., 59: 2820-2824, 1999.